This is an increase of 560 million over the previous year. The investor is one of Solon and Vaccibody’s largest shareholders.
According to the latest data from the Brønnøysund register, Tore Aksel Voldberg made 880 million Norwegian kroner last year through his two investment companies Dukat and Skøien. This is an increase of NOK 560 million over the previous year.
That is the newspaper
Business today Who mentioned the case first.
In 2018, Waldberg’s annual profit was NOK 90 million. By 2020, this number will increase by 877.78%.
This year, like last year, Skøien has achieved its best development, with its performance increasing from NOK 241.5 million to NOK 824 million.
The total equity of investors also jumped from NOK 520,000 to NOK 1.3 billion.
Waldberg has invested in Vaccibody for research and development of cancer vaccines. According to Infront, he is the fifth largest shareholder and owns 9.11 million shares of the company. According to Infront’s data, as of the last update date (Monday, April 19), the investment value was 715 million Norwegian kroner.
Waldberg is the third largest shareholder of the real estate company Solon, where his shares (as of April 19) are valued at 351 million Norwegian kroner. During the price drop, he also bought Kahoot again and owns 220 million Norwegian kroner shares in the testing company. This is his third largest investment through Skøien.
So far, E24 has not successfully contacted Voldberg.